The Study of Cost-Effectiveness of Rivaroxaban versus Warfarin in Patients with Atrial Fibrillation Who Developed Ischemic Stroke

Figure 1

Tornado diagram of cost-effectiveness to prevent of bleeding for patients with AF under treatment with rivaroxaban and warfarin.